Compare HIND & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HIND | FOFO |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Hong Kong |
| Employees | 18 | 14 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 15.2M |
| IPO Year | 2016 | N/A |
| Metric | HIND | FOFO |
|---|---|---|
| Price | $2.17 | $2.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 10.8K | ★ 24.0K |
| Earning Date | 05-20-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $1.75 |
| 52 Week High | $12.87 | $68.00 |
| Indicator | HIND | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 44.51 |
| Support Level | $1.78 | $1.75 |
| Resistance Level | $2.33 | $3.38 |
| Average True Range (ATR) | 0.09 | 0.21 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 0.00 | 45.30 |
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.